Radioactive main group and rare earth metals for imaging and therapy
TI Kostelnik, C Orvig - Chemical reviews, 2018 - ACS Publications
Radiometals possess an exceptional breadth of decay properties and have been applied to
medicine with great success for several decades. The majority of current clinical use …
medicine with great success for several decades. The majority of current clinical use …
Production and clinical applications of radiopharmaceuticals and medical radioisotopes in Iran
During past 3 decades, nuclear medicine has flourished as vibrant and independent
medical specialty in Iran. Since that time, more than 200 nuclear physicians have been …
medical specialty in Iran. Since that time, more than 200 nuclear physicians have been …
Development of a 68Ga-Fluorinated Porphyrin Complex as a Possible PET Imaging Agent
Y Fazaeli, AR Jalilian, MM Amini, K Ardaneh… - Nuclear medicine and …, 2012 - Springer
Aim Due to the interesting pharmacologic properties of porphyrins, the idea of developing a
possible tumor imaging agent using PET by incorporating 68 Ga into a suitable porphyrin …
possible tumor imaging agent using PET by incorporating 68 Ga into a suitable porphyrin …
Synthesis and evaluation of [67Ga]-AMD3100: A novel imaging agent for targeting the chemokine receptor CXCR4
In order to develop a possible CXC chemokine receptor type 4 (CXCR4) imaging agent for
oncological scintigraphy,[67Ga]-labeled 1, 1′-[1, 4-Phenylene-bis (methylene)] bis (1, 4, 8 …
oncological scintigraphy,[67Ga]-labeled 1, 1′-[1, 4-Phenylene-bis (methylene)] bis (1, 4, 8 …
Preparation and Evaluation of 68Ga-ECC as a PET Renal Imaging Agent
A Mirzaei, AR Jalilian, A Aghanejad, M Mazidi… - Nuclear medicine and …, 2015 - Springer
Purpose Development of a gallium-68-labeled renal tracer can be a good substitute for Tc-
99m, a known SPECT tracer. In this study, effort was made to develop 68 Ga …
99m, a known SPECT tracer. In this study, effort was made to develop 68 Ga …
Radiosynthesis and biodistribution studies of [62Zn/62Cu]–plerixafor complex as a novel in vivo PET generator for chemokine receptor imaging
In order to develop a possible CXC chemokine receptor type 4 (CXCR4) imaging agent for
oncological scintigraphy,[62 Zn] labeled 1, 1′-[1, 4-phenylenebis (methylene)] bis-1, 4, 8 …
oncological scintigraphy,[62 Zn] labeled 1, 1′-[1, 4-phenylenebis (methylene)] bis-1, 4, 8 …
[HTML][HTML] Preparation and quality control of 68Ga-citrate for PET applications
A Aghanejad, AR Jalilian, K Ardaneh… - Asia Oceania Journal …, 2015 - ncbi.nlm.nih.gov
Objective (s): In nuclear medicine studies, gallium-68 (8 Ga) citrate has been recently known
as a suitable infection agent in positron emission tomography (PET). In this study, by …
as a suitable infection agent in positron emission tomography (PET). In this study, by …
Preparation, nano purification, quality control and labeling optimization of [64Cu]-5,10,15,20-tetrakis (penta fluoro phenyl) porphyrin complex as a possible imaging …
Y Fazaeli, AR Jalilian, MM Amini… - … of Radioanalytical and …, 2013 - Springer
Cu-64 was produced via the 68 Zn (p, αn) 64 Cu nuclear reaction (≈ 200 mCi,> 95%
chemical yield at 180 μA for 1.1 h irradiation,(radionuclidic purity> 96%, copper-67 as …
chemical yield at 180 μA for 1.1 h irradiation,(radionuclidic purity> 96%, copper-67 as …
Gallium compounds in nuclear medicine and oncology
P Mikuš, M Melník, A Forgácsová… - Main Group Metal …, 2014 - degruyter.com
An overview of the most important gallium compounds in nuclear medicine and oncology in
the two last decades, with an emphasis on the last decade (especially the last 5 years), is …
the two last decades, with an emphasis on the last decade (especially the last 5 years), is …
[PDF][PDF] Preparation and quality control of scandium-46 bleomycin as a possible therapeutic agent
L Moghaddam-Banaem, AR Jalilian… - Iranian Journal of …, 2012 - researchgate.net
Introduction: Due to interesting therapeutic properties of 46Sc and antineoblastic antibiotic,
bleomycin (BLM), 46Sc-bleomycin (46Sc-BLM) was developed as a possible therapeutic …
bleomycin (BLM), 46Sc-bleomycin (46Sc-BLM) was developed as a possible therapeutic …